… for patients diagnosed with pancreatic cancer is less than 10… pancreatic cancer at an early
stage or identify precursors that are destined to progress to malignancy. The National Cancer …

… Identification of noninvasive genetic biomarkers that could direct therapy in patients whose
cases are amenable to pancreatic cancer … Genome Atlas cohort for validation. We used Cox …

… Purpose: Discriminant markers for pancreatic cancer detection are needed. We sought to
identify and validate methylated DNA markers for pancreatic cancer using next-generation …

Substantial alterations at the multi-omics level of pancreatic cancer (PC) impede the possibility
to diagnose and treat patients in early stages. Herein, we conducted an integrative omics-…

… This research has developed and validated a new algorithm designed to quantify the
absolute risk of having pancreatic cancer, which is either currently present or likely to become …

… in timing of cancer events also are similar to those of other validation studies,10, 12 although
neither of these two studies examined the timing of the identification of pancreatic cancer. …

… /or validation of pancreatic cancer early detection … validation of the three-marker panel in
independent prediagnostic cohorts will be required to demonstrate utility for pancreatic cancer …

… remain unclear in pancreatic cancer. It’s necessary to identify the hub genes in pancreatic
cancer and explore the novel potential predictors in the prognosis of pancreatic cancer. We …

… images of 370 patients with pancreatic cancer and 320 controls from a … validation (295
patients with pancreatic cancer and 256 controls) and testing (75 patients with pancreatic cancer …

… Gender-specific risk prediction models for pancreatic cancer were developed and validated
for … high-risk individuals who may benefit from increased surveillance for pancreatic cancer. …